 Molecular Partners AG NASDAQ: MOLN has provided an update regarding the Emergency Use Application EUA for ensovibep, a DARPin antiviral therapeutic candidate to treat COVID-19. The Company says that EUA, in review with the FDA, may require additional clinical data to be. 